JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Your company account is blocked and you cannot place orders. If you have questions, please contact your company administrator.

྾

Sonelokimab , CAS No.1414386-05-2

Item Number

S646142

Grouped product items
SKU	Size	Availability	Price	Qty
S646142-1mg	1mg	Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding.	$541.90	+-

View related series

Basic Description

Biochemical and Physiological Mechanisms	Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody comprised of monovalent camelid-derived nanobodies specific to human interleukin (IL)-17A, IL-17F , and human serum albumin VHHs. Sonelokimab has the potential for plaque-type psoriasis research[
Storage Temp	Store at -20°C
Shipped In	Ice chest + Ice pads
Product Description	Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody comprised of monovalent camelid-derived nanobodies specific to human interleukin (IL)-17A, IL-17F , and human serum albumin VHHs. Sonelokimab has the potential for plaque-type psoriasis research IC50& Target:IL-17A\|IL-17F

Canonical SMILES	[Sonelokimab]

C of A & Other Certificates(BSE/TSE, COO):

Analytical Chart:

Determine the necessary mass, volume, or concentration for preparing a solution.

Determine the dilution needed to prepare a stock solution.